Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

J. Trousil, NK. Dal, F. Fenaroli, I. Schlachet, P. Kubíčková, O. Janoušková, E. Pavlova, M. Škorič, K. Trejbalová, O. Pavliš, A. Sosnik

. 2022 ; 18 (28) : e2201853. [pub] 20220612

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22025371

In this work, levofloxacin (LVX), a third-generation fluoroquinolone antibiotic, is encapsulated within amphiphilic polymeric nanoparticles of a chitosan-g-poly(methyl methacrylate) produced by self-assembly and physically stabilized by ionotropic crosslinking with sodium tripolyphosphate. Non-crosslinked nanoparticles display a size of 29 nm and a zeta-potential of +36 mV, while the crosslinked counterparts display 45 nm and +24 mV, respectively. The cell compatibility, uptake, and intracellular trafficking are characterized in the murine alveolar macrophage cell line MH-S and the human bronchial epithelial cell line BEAS-2B in vitro. Internalization events are detected after 10 min and the uptake is inhibited by several endocytosis inhibitors, indicating the involvement of complex endocytic pathways. In addition, the nanoparticles are detected in the lysosomal compartment. Then, the antibacterial efficacy of LVX-loaded nanoformulations (50% w/w drug content) is assessed in MH-S and BEAS-2B cells infected with Staphylococcus aureus and the bacterial burden is decreased by 49% and 46%, respectively. In contrast, free LVX leads to a decrease of 8% and 5%, respectively, in the same infected cell lines. Finally, intravenous injection to a zebrafish larval model shows that the nanoparticles accumulate in macrophages and endothelium and demonstrate the promise of these amphiphilic nanoparticles to target intracellular infections.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025371
003      
CZ-PrNML
005      
20221031100329.0
007      
ta
008      
221017s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/smll.202201853 $2 doi
035    __
$a (PubMed)35691939
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Trousil, Jiří $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, 162 00, Czech Republic $1 https://orcid.org/0000000249797247
245    10
$a Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen / $c J. Trousil, NK. Dal, F. Fenaroli, I. Schlachet, P. Kubíčková, O. Janoušková, E. Pavlova, M. Škorič, K. Trejbalová, O. Pavliš, A. Sosnik
520    9_
$a In this work, levofloxacin (LVX), a third-generation fluoroquinolone antibiotic, is encapsulated within amphiphilic polymeric nanoparticles of a chitosan-g-poly(methyl methacrylate) produced by self-assembly and physically stabilized by ionotropic crosslinking with sodium tripolyphosphate. Non-crosslinked nanoparticles display a size of 29 nm and a zeta-potential of +36 mV, while the crosslinked counterparts display 45 nm and +24 mV, respectively. The cell compatibility, uptake, and intracellular trafficking are characterized in the murine alveolar macrophage cell line MH-S and the human bronchial epithelial cell line BEAS-2B in vitro. Internalization events are detected after 10 min and the uptake is inhibited by several endocytosis inhibitors, indicating the involvement of complex endocytic pathways. In addition, the nanoparticles are detected in the lysosomal compartment. Then, the antibacterial efficacy of LVX-loaded nanoformulations (50% w/w drug content) is assessed in MH-S and BEAS-2B cells infected with Staphylococcus aureus and the bacterial burden is decreased by 49% and 46%, respectively. In contrast, free LVX leads to a decrease of 8% and 5%, respectively, in the same infected cell lines. Finally, intravenous injection to a zebrafish larval model shows that the nanoparticles accumulate in macrophages and endothelium and demonstrate the promise of these amphiphilic nanoparticles to target intracellular infections.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    12
$a chitosan $7 D048271
650    _2
$a lidé $7 D006801
650    _2
$a makrofágy $x metabolismus $7 D008264
650    _2
$a myši $7 D051379
650    12
$a nanočástice $7 D053758
650    _2
$a dánio pruhované $7 D015027
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dal, Nils-Jørgen K $u Department of Biosciences, University of Oslo, Oslo, 0371, Norway
700    1_
$a Fenaroli, Federico $u Department of Biosciences, University of Oslo, Oslo, 0371, Norway
700    1_
$a Schlachet, Inbar $u Laboratory of Pharmaceutical Nanomaterials Science, Faculty of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel
700    1_
$a Kubíčková, Pavla $u Military Health Institute, Military Medical Agency, Prague, 160 00, Czech Republic
700    1_
$a Janoušková, Olga $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, 162 00, Czech Republic $u Department of Biology, Faculty of Science, University of J. E. Purkyně, Ústí nad Labem, 400 96, Czech Republic
700    1_
$a Pavlova, Ewa $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, 162 00, Czech Republic
700    1_
$a Škorič, Miša $u Department of Pathological Morphology and Parasitology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Brno, 612 42, Czech Republic
700    1_
$a Trejbalová, Kateřina $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague, 142 20, Czech Republic
700    1_
$a Pavliš, Oto $u Military Health Institute, Military Medical Agency, Prague, 160 00, Czech Republic
700    1_
$a Sosnik, Alejandro $u Laboratory of Pharmaceutical Nanomaterials Science, Faculty of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel $1 https://orcid.org/0000000347044599
773    0_
$w MED00008487 $t Small $x 1613-6829 $g Roč. 18, č. 28 (2022), s. e2201853
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35691939 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100327 $b ABA008
999    __
$a ok $b bmc $g 1854872 $s 1176661
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 18 $c 28 $d e2201853 $e 20220612 $i 1613-6829 $m Small $n Small $x MED00008487
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options